(Q70997297)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599867%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599867%20AND%20SRC:MED&resulttype=core&format=json

chronic lymphocytic leukemia

15 October 2019

main subject

1 reference

L E Robertson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599867%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

A W Denny

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599867%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Y O Huh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599867%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

W Plunkett

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599867%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

M J Keating

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599867%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

J A Nelson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599867%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599867%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

15 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599867%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599867%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599867%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

445-450

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599867%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s002800050410

15 October 2019

exact match

0 references

cites work

Prognostic significance of immune function parameters in patients with chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1007%2FS002800050410

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050410

Discrepancy between phenotypic and functional features of natural killer T-lymphocytes in B-cell chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050410

Reduced natural killer T-cells in B-cell chronic lymphocytic leukaemia identified by three monoclonal antibodies: Leu-11, A10, AB8.28

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050410

Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050410

Restoration of impaired natural killer cell activity of B-chronic lymphocytic leukemia patients by recombinant interleukin-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050410

Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050410

Rapid restoration of natural killer activity following treatment with 2-chlorodeoxyadenosine in 22 patients with hairy-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050410

Selective immunotoxic effects in mice treated with the adenosine deaminase inhibitor 2'-deoxycoformycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050410

Large granular lymphocytes from B-chronic lymphocytic leukemia patients inhibit normal B cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050410

Purine nucleoside modulation of functions of human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050410

Role of natural killer cells in the modulation of primary antibody production by purine nucleosides and their analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050410

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050410

Overview of possible relation of defects in purine metabolism to immune deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050410

Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050410

Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.

21 January 2018

1 reference

12 December 2020

Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis

1 reference

12 December 2020

Augmentation of murine natural killer cell activity by swainsonine, a new antimetastatic immunomodulator

1 reference

12 December 2020

Recombinant alpha-2b-interferon may restore natural-killer activity in patients with B-chronic lymphocytic leukemia

1 reference

12 December 2020

Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphate

1 reference

12 December 2020

Adenosine receptors and modulation of natural killer cell activity by purine nucleosides

1 reference

12 December 2020

Selective modulation of antibody response and natural killer cell activity by purine nucleoside analogues

1 reference

12 December 2020

Termination of DNA synthesis by 9-beta-D-arabinofuranosyl-2-fluoroadenine. A mechanism for cytotoxicity

1 reference

12 December 2020

Dual mode of inhibition of purified DNA ligase I from human cells by 9-beta-D-arabinofuranosyl-2-fluoroadenine triphosphate

1 reference

12 December 2020

Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase.

1 reference

12 December 2020

Defective spontaneous and antibody-dependent cytotoxicity mediated by E-rosette-positive and E-rosette-negative cells in untreated patients with chronic lymphocytic leukemia: augmentation by in vitro treatment with interferon

1 reference

12 December 2020

Immunobiology of malignant B cells and immunoregulatory cells in B-chronic lymphocytic leukemia.

1 reference

12 December 2020

Evidence that large granular lymphocytes from B-CLL patients with hypogammaglobulinemia down-regulate B-cell immunoglobulin synthesis

1 reference

12 December 2020

Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo

1 reference

12 December 2020

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia

1 reference

12 December 2020

The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect

1 reference

12 December 2020

Clinical staging of chronic lymphocytic leukemia

1 reference

12 December 2020

Effects on human peripheral lymphocytes of in vivo administration of 9-beta-D-arabinofuranosyl-2-fluoroadenine-5'-monophosphate (NSC 312887), a new purine antimetabolite

1 reference

12 December 2020

Identifiers

DOI

10.1007/S002800050410

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599867%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference